Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

RIGEL PHARMACEUTICALS INC

RIGL · Nasdaq · CIK 0001034842 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

25 Form 4 transaction lines observed in the same window
2 sales · 23 option, withholding, award, gift or other lines

Last qualifying purchase2022-06-09 · RODRIGUEZ RAUL R · $690.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Schorno Dean LEVP & Chief Financial Officer
○○○○
Ali-Jackson KamilDirector
○▼▼
Santos David AEVP, Chief Commercial Officer
○○
RODRIGUEZ RAUL RCEO, President
○○
Furey Raymond J.EVP, GC, CCO & Corp Sec
○○
HANNAH ALISON L.Director
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 6 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-06-09 · RODRIGUEZ RAUL R.

Recent Form 4 activity

0Purchases
3Sales
44Other Form 4 lines
35SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING2 sale line(s) · context only
OTHER23 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
2,855,433
Previous report
3,191,811
Avg daily volume
256,338
Days to cover
11.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2022-06-09RODRIGUEZ RAUL RPurchase (P)Common Stock1,000,000USD 0.69USD 690,000SEC filing ↗

Form 4 evidence

47 transaction lines in the latest 365-day window; 119 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-02Schorno Dean LOption exercise / conversion (M)Common Stock4,600USD 21.72USD 99,929SEC filing ↗
2026-09-01Schorno Dean LTax withholding (F)Common Stock928USD 47.50USD 44,080SEC filing ↗
2026-09-01Santos David ATax withholding (F)Common Stock874USD 47.50USD 41,515SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-02Schorno Dean LOption exercise / conversion (M)Common Stock4,600USD 21.72USD 99,929SEC filing ↗
2026-09-01Schorno Dean LTax withholding (F)Common Stock928USD 47.50USD 44,080SEC filing ↗
2026-09-01Santos David ATax withholding (F)Common Stock874USD 47.50USD 41,515SEC filing ↗
2026-09-01RODRIGUEZ RAUL RTax withholding (F)Common Stock2,424USD 47.50USD 115,140SEC filing ↗
2026-09-01Furey Raymond J.Tax withholding (F)Common Stock877USD 47.50USD 41,658SEC filing ↗
2026-07-08HANNAH ALISON L.Award / grant (A)Common Stock24,400USD 0.00USD 0SEC filing ↗
2026-06-22Ali-Jackson KamilSale (S)Common Stock2,500USD 35.00USD 87,500SEC filing ↗
2026-06-01Schorno Dean LOption exercise / conversion (M)Common Stock3,381USD 14.83USD 50,139SEC filing ↗
2026-06-01Schorno Dean LTax withholding (F)Common Stock928USD 29.86USD 27,710SEC filing ↗
2026-06-01Santos David ATax withholding (F)Common Stock874USD 29.86USD 26,098SEC filing ↗
2026-06-01Rojkjaer LisaTax withholding (F)Common Stock850USD 29.86USD 25,381SEC filing ↗
2026-06-01RODRIGUEZ RAUL RTax withholding (F)Common Stock2,424USD 29.86USD 72,381SEC filing ↗
2026-06-01Furey Raymond J.Tax withholding (F)Common Stock877USD 29.86USD 26,187SEC filing ↗
2026-05-26Ali-Jackson KamilSale (S)Common Stock2,500USD 29.17USD 72,925SEC filing ↗
2026-05-15Wasman JaneAward / grant (A)Common Stock5,750USD 0.00USD 0SEC filing ↗
2026-05-15MOOS WALTER HAward / grant (A)Common Stock5,750USD 0.00USD 0SEC filing ↗
2026-05-15MILLER MICHAEL PATRICKAward / grant (A)Common Stock5,750USD 0.00USD 0SEC filing ↗
2026-05-15LAPOINTE ANTHONY GREGGAward / grant (A)Common Stock5,750USD 0.00USD 0SEC filing ↗
2026-05-15HANNAH ALISON L.Award / grant (A)Common Stock5,750USD 0.00USD 0SEC filing ↗
2026-05-15Frohlich Mark WAward / grant (A)Common Stock5,750USD 0.00USD 0SEC filing ↗
2026-05-15Ali-Jackson KamilAward / grant (A)Common Stock5,750USD 0.00USD 0SEC filing ↗
2026-02-20MOOS WALTER HSale (S)Common Stock4,000USD 36.36USD 145,440SEC filing ↗
2026-02-20MOOS WALTER HOption exercise / conversion (M)Common Stock4,000USD 24.00USD 96,000SEC filing ↗
2026-02-17Schorno Dean LAward / grant (A)Common Stock20,636USD 0.00USD 0SEC filing ↗
2026-02-17Santos David AAward / grant (A)Common Stock19,430USD 0.00USD 0SEC filing ↗
2026-02-17Rojkjaer LisaAward / grant (A)Common Stock18,894USD 0.00USD 0SEC filing ↗
2026-02-17RODRIGUEZ RAUL RAward / grant (A)Common Stock53,915USD 0.00USD 0SEC filing ↗
2026-02-17Furey Raymond J.Award / grant (A)Common Stock19,497USD 0.00USD 0SEC filing ↗
2026-02-10Schorno Dean LTax withholding (F)Common Stock3,546USD 34.62USD 122,763SEC filing ↗
2026-02-10Santos David ATax withholding (F)Common Stock3,546USD 34.62USD 122,763SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRIGL
CIK0001034842
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history119 transaction lines from 2021-05-19 to 2026-09-02
1 P purchase lines · 21 S sale lines · 97 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.